All In Biotech

Free tool

FAERS Monitor: Cytomel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 010379 or its brand name (Cytomel, Liothyronine Sodium). Reports on generic versions are filed under their own applications.

Reports

8,771

Serious

3,983

45% of reports

Hospitalization

1,511

Death reported

208

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective969
  • headache887
  • fatigue860
  • nausea587
  • dyspnoea562
  • pain491
  • hypertension471
  • malaise451
  • weight increased443
  • hypothyroidism433
  • feeling abnormal420
  • dizziness402
  • diarrhoea390
  • off label use377
  • insomnia361

Reports by year received

View as table
YearReports
200479
200591
200679
2007129
2008170
2009153
2010269
2011229
2012294
2013314
2014314
2015515
2016727
2017472
2018558
2019560
2020640
2021505
2022946
2023510
2024443
2025427
2026347

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,388 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypothyroidismSignal43333.030.013,222
hypertensionSignal4715.34.91,671
weight increasedSignal4434.84.31,320
feeling abnormalSignal4204.23.81,034
headacheSignal8873.43.21,541
insomniaSignal3613.32.9568
fatigueSignal8602.72.5915
malaiseSignal4512.52.3400
dyspnoeaSignal5622.42.2461
dizziness4021.91.8184
pain4911.91.8221
nausea5871.81.6207
drug ineffective9691.81.7341
diarrhoea3901.41.356
off label use3771.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.